Results 21 to 30 of about 123,719 (312)

The association between the apolipoprotein B/A-I ratio and coronary calcification may differ depending on kidney function in a healthy population. [PDF]

PLoS ONE, 2017
The apolipoprotein B/A-1 ratio has been reported to be one of the strongest risk predictors of cardiovascular events. However, its prognostic value for cardiovascular disease is still uncertain, especially in patients with chronic kidney disease.
Seok-Hyung Kim, Donghwan Oh, Kwon Soo Jung, Jung Eun Lee, Hyunwook Kim, Hyung Jong Kim, Beom Seok Kim, Hyeong Cheon Park, Byoung Kwon Lee, Hoon Young Choi   +9 more
doaj   +1 more source

Apolipoprotein[a] is not associated with apolipoprotein B in human liver

Journal of Lipid Research, 1994
The aim of this research was to determine whether apolipoprotein[a] (apo[a]) is linked to apolipoprotein B (apoB) in human liver. Four ELISAs were developed: 1) a competition assay that measures apoB; 2) a competition assay that measures apo[a]; 3) a capture assay based on capture of apo[a] by a polyclonal antibody and detection of co-immobilized apoB ...
J Wilkinson, L H Munro, J A Higgins
openaire   +3 more sources

Effect of Early Enteral Feeding on Apolipoprotein AI Levels and High-Density Lipoprotein Heterogeneity in Preterm Infants [PDF]

, 2001
Background/Aim: We have previously shown that infants receiving total parenteral nutrition have low apolipoprotein Al levels which are associated with high-density lipoprotein (HDL) class distributions as in lecithin:cholesterol acyltransferase ...
Berthold Koletzkob, Koletzko, Berthold, Yvonne Göbelb, Genzel-Boroviczény, Orsolya, Göbel, Yvonne, Orsolya Genzel-boroviczénya   +5 more
core   +1 more source

Separation and quantification of apolipoprotein B-48 and other apolipoproteins by dynamic sieving capillary electrophoresis

Journal of Lipid Research, 1997
Apolipoprotein-B-48 is a structural protein exclusively associated with post-prandial lipoproteins (chylomicrons). Apolipoprotein B-48 would be a useful marker to monitor the kinetics of chylomicrons in vivo, however, its quantitation is limited because ...
S D Proctor, J C Mamo
doaj   +1 more source

Genetic variants in Apolipoprotein AV alter triglyceride concentrations in pregnancy. [PDF]

, 2003
BACKGROUND: Triglyceride concentrations are raised in pregnancy and are considered a key fetal fuel. Several gene variants are known to alter triglyceride concentrations, including those in the Apolipoprotein E (ApoE), Lipoprotein Lipase (LPL), and most ...
Andrew T Hattersley, Beatrice Knight, Kirsten J Ward, Ward Kirsten J, Knight Beatrice, Hattersley, Andrew T, Ward, Kirsten J, Maurice B Salzmann, Timothy M Frayling, Frayling, Timothy M, Beverley Shields, Shields, Beverley, Salzmann Maurice B, Hattersley Andrew T, Shields Beverley, Frayling Timothy M, Knight, Beatrice, Salzmann, Maurice B   +17 more
core   +1 more source

Identification of disulfide-linked apolipoprotein species in human lipoproteins

Journal of Lipid Research, 1993
We wished to determine whether apolipoprotein C-IIToronto, a mutant form of apolipoprotein C-II that contains a C-terminal cysteine residue, exists as a monomeric species or as multiple disulfide-linked species in plasma lipoproteins.
PW Connelly, GF Maguire, C Vezina, RA Hegele, JA Little   +4 more
doaj   +1 more source

IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study. [PDF]

, 2015
IgG anti-apolipoprotein A-1 (IgG anti-apoA-1) antibodies are present in patients with systemic lupus erythematosus (SLE) and may link inflammatory disease activity and the increased risk of developing atherosclerosis and cardiovascular disease (CVD) in ...
Davari, M, Yiannis Ioannou, Isenberg, D, Paul Bassett, Rahman, A, David Isenberg, Anisur Rahman, Maria Davari, Alber, KF, Ioannou, Y, Oliver Leach, Giles, I, Bassett, P, Karim Alber, Ian Giles, Leach, O, Sara Croca, Chambers, S, Croca, S, Sharon Chambers   +19 more
core   +1 more source

Clinical significance of fasting and postprandial lipemia in obese and non-obese subjects [PDF]

Zanco Journal of Medical Sciences, 2018
Background and objective: Postprandial lipemia is a risk marker for the presence or progression of cardiovascular disease. Identifying factors affecting lipoprotein metabolism in postprandial state is of interest in order to find ways for prevention of ...
Muzha M. Baqi, Abdulqader A. Alnaqishbandi   +1 more
doaj   +1 more source

Consensus document for lipid profile testing and reporting in Spanish clinical laboratories: what parameters should a basic lipid profile include?

Advances in Laboratory Medicine, 2023
Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice.
Arrobas Velilla Teresa, Guijarro Carlos, Ruiz Raquel Campuzano, Piñero Manuel Rodríguez, Valderrama Marcos José Francisco, Pérez Pérez Antonio, Botana López Antonio M., López Ana Morais, García Donaire José Antonio, Obaya Juan Carlos, Castilla-Guerra Luis, Carratalá Vicente Pallares, Cabello Isabel Egocheaga, Lazo Mercedes Salgueira, Castellanos Rodrigo María Mar, Mostaza Prieto José María, Gómez Doblas Juan José, Buño Soto Antonio,   +18 more
doaj   +1 more source

Clinical significance of leptin in systemic lupus erythematosus

Современная ревматология, 2021
Objective: to study the frequency of hyperleptinemia in patients with systemic lupus erythematosus (SLE), its relationship with clinical and laboratory manifestations of the disease, drug therapy, and other metabolic disorders.Patients and methods.
L. V. Kondratyeva, T. A. Panafidina, T. V. Popkova, Yu. N. Gorbunova, M. V. Cherkasova   +4 more
doaj   +1 more source